Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms

Nutrition and Cancer

Volumn 62, Issue 2, 2010, Pages 243-251

  Delort, Laetitia ^a   Satih, Samir ^a   Kwiatkowski, Fabrice ^b   Bignon, Yves Jean ^a   Bernard Gallon, Dominique J ^a  

^a CRNH AUVERGNE   (France)

^b CENTRE JEAN PERRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1B1; GLUTATHIONE TRANSFERASE P1;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; ESTROGEN METABOLISM; FEMALE; GENETIC MODEL; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PENETRANCE; SINGLE NUCLEOTIDE POLYMORPHISM; XENOBIOTIC METABOLISM;

ADULT; AGED; AGED, 80 AND OVER; ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; CYTOCHROME P-450 ENZYME SYSTEM; ESTROGENS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; XENOBIOTICS;

EID: 76749149658     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903305300     Document Type: Article

References (37)

1. Parkin DM: International variation. Oncogene 23, 6329-6340, 2004.
2. de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, Oosterwijk JC, et al.: Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 39, 225-242, 2002.
3. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, et al.: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8, 843-854, 1999.
4. Dumitrescu RG and Cotarla I: Understanding breast cancer risk-where do we stand in 2005? J Cell Mol Med 9, 208-221, 2005.
5. Cheng TC, Chen ST,Huang CS, FuYP,Yu JC, et al.:Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113, 345-353, 2005.
6. Mitrunen K and Hirvonen A: Molecular epidemiology of sporadic breast cancer: the role of polymorphic genes involved in estrogen biosynthesis and metabolism. Mutat Res 544, 9-41, 2003.
7. Junien C: Evaluation du risque de cancer du sein ̀a l'aide d'un mod̀ele multiǵenique constitut́e de g̀enes de faible ṕeńetrance impliqúes dans les metabolismes des x́enobiotique et des oestrog̀enes. [Colon cancer and nutritional genetics: modifier genes]. Ann Med Interne (Paris) 152, 337-351, 2001.
8. Sinha R and Caporaso N: Diet, genetic susceptibility and human cancer etiology. J Nutr 129, 556S-559S, 1999.
9. Hein DW: Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 506-507, 65-77, 2002.
10. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, et al.: Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9, 29-42, 2000.
11. Dawling S, Roodi N, Mernaugh RL, Wang X, and Parl FF: Catechol-Omethyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 61, 6716-6722, 2001.
12. Livak KJ: Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 14, 143-149, 1999.
13. Kwiatkowski F, Girard M, Hac̀ene K, and Berlie J: SEM: a suitable statistical software adapted for research in oncology. Bull Cancer 87, 715-721, 2000.
14. Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, et al.: Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15, 2961-2963, 1994.
15. Hanna IH, Dawling S, Roodi N, Guengerich FP, and Parl FF: Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60, 3440-3444, 2000.
16. Ishibe N, Hankinson SE, Colditz GA, Spiegelman D, Willett WC, et al.: Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res 58, 667-671, 1998.
17. Rebbeck TR, Rosvold EA, Duggan DJ, Zhang J, and Buetow KH: Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer. Cancer Epidemiol Biomarkers Prev 3, 511-514, 1994.
18. ZhangY,Wise JP, Holford TR, XieH, Boyle P, et al.: Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Am J Epidemiol 160, 1177-1183, 2004.
19. da Fonte de Amorim L, Rossini A, Mendonca G, Lotsch P, de Almeida Simao T, et al.: CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women. Cancer Lett 181, 179-186, 2002.
20. Krajinovic M, Ghadirian P, Richer C, Sinnett H, Gandini S, et al. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogenmetabolizing enzymes and gene-environment interactions. Int J Cancer 92, 220-225, 2001.
21. Miyoshi Y and Noguchi S: Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women. Biomed Pharmacother 57, 471-481, 2003. (Pubitemid 37452417)
22. Boyapati SM, Shu XO, Gao YT, Cai Q, Jin F, et al.: Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women. Cancer 103, 2228-2235, 2005.
23. Bailey LR, Roodi N, Dupont WD, and Parl FF: Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 58, 5038-5041, 1998.
24. De Vivo I, Hankinson SE, Li L, Colditz GA, and Hunter DJ: Association of CYP1B1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 11, 489-492, 2002.
25. Rylander-Rudqvist T, Wedren S, Granath F, Humphreys K, Ahlberg S, et al.: Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk. Carcinogenesis 24, 1533-1539, 2003.
26. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, et al.: Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96, 936-945, 2004.
27. Lee KM, Abel J, Ko Y, Harth V, ParkWY, et al.: Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. Br J Cancer 88, 675-678, 2003.
28. Thyagarajan B, Brott M, Mink P, Folsom AR, Anderson KE, et al. CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study. Cancer Lett 207, 183-189, 2004.
29. Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, et al.: Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9, 147-150, 2000.
30. Watanabe J, Shimada T, Gillam EM, Ikuta T, Suemasu K, et al.: Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10, 25-33, 2000.
31. Kocabas NA, Sardas S, Cholerton S, Daly AK, and Karakaya AE: Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol 76, 643-649, 2002.
32. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, et al.: Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59, 4870-4875, 1999.
33. Huang Z, Fasco MJ, Figge HL,Keyomarsi K, andKaminsky LS: Expression of cytochromes P450 in human breast tissue and tumors. Drug MetabDispos 24, 899-905, 1996.
34. Helzlsouer KJ, Selmin O, Huang HY, Strickland PT, Hoffman S, et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 90, 512-518, 1998.
35. Ballard-BarbashR:Anthropometry and breast cancer: body size-amoving target. Cancer 74, 1090-1100, 1994.
36. Mannisto S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, et al.: Body-size indicators and risk of breast cancer according to menopause and estrogenreceptor status. Int J Cancer 68, 8-13, 1996.
37. Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, et al.: Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol 150, 1316-1324, 1999.